Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesNikolaus Marx, Konstantinos C. Koskinas, Maciej Lesiak et al.|European Heart Journal|2023Cited by 1.4k
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes StatusStefan D. Anker, Milton Packer, Javed Butler et al.|Circulation|2020Cited by 350
C-Peptide Induces Vascular Smooth Muscle Cell ProliferationDaniel Walcher, Nikolaus Marx|Circulation Research|2006Cited by 94
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fractionArjun Pandey, Subodh Verma, Deepak L. Bhatt et al.|European Heart Journal|2023Cited by 92